Compared to Estimates, AptarGroup (ATR) Q3 Earnings: A Look at Key Metrics

AptarGroup (ATR) reported $961.13 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 5.7%. EPS of $1.62 for the same period compares to $1.49 a year ago.The reported revenue represents a surprise of +0.91% over the Zacks Consensus Estimate of $952.51 million. With the consensus EPS estimate being $1.57, the EPS surprise was +3.18%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how AptarGroup performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Net Sales- Aptar Beauty: $327.77 million compared to the $309.91 million average estimate based on two analysts. The reported number represents a change of +8.2% year over year.Net Sales- Aptar Closures: $187.95 million compared to the $190.73 million average estimate based on two analysts. The reported number represents a change of +1.1% year over year.Net Sales- Aptar Pharma: $445.41 million versus the two-analyst average estimate of $445.73 million. The reported number represents a year-over-year change of +5.9%.Adjusted EBITDA- Aptar Pharma: $165.77 million versus the two-analyst average estimate of $157.17 million.Adjusted EBITDA- Aptar Closures: $30.34 million versus the two-analyst average estimate of $32.49 million.Adjusted EBITDA- Corporate & Other: $-13.26 million compared to the $-19.22 million average estimate based on two analysts.Adjusted EBITDA- Aptar Beauty: $39.75 million versus the two-analyst average estimate of $42.62 million.View all Key Company Metrics for AptarGroup here>>>Shares of AptarGroup have returned -7.3% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AptarGroup, Inc. (ATR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks